GSA CAPITAL PARTNERS LLP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$762
+173.1%
568,298
+591.7%
0.06%
+85.7%
Q4 2022$279
-100.0%
82,162
-57.2%
0.04%
-77.4%
Q4 2021$1,234,000
+19.8%
191,976
+8.5%
0.16%
+47.6%
Q3 2021$1,030,000
+242.2%
176,996
+507.4%
0.10%
+208.8%
Q2 2021$301,000
-6.5%
29,138
-4.8%
0.03%
-35.8%
Q1 2021$322,000
-5.0%
30,592
+39.7%
0.05%
-3.6%
Q4 2020$339,00021,9030.06%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders